Drug Database
Back to search

France· FR:60938745

PERFANE 100 mg/20 ml, solution injectable à diluer pour voie I.V.

A enoximone product containing énoximone, registered in France by CARINOPHARM (ALLEMAGNE). The same ATC class is registered in 4 of our 19 countries.

ATC C01CE03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPERFANE 100 mg/20 ml, solution inject…ATCC01CE03REGISTER NO.FR:60938745PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about énoximoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Enoximone is registered in 4 of 19 countries.

Countries holding a registration under ATC C01CE03 (enoximone), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 1 of them publish a price we can compare per daily dose
Search enoximone products by name

Enoximone · ATC C01CE03

4 / 19 countries

  • Franceprice
  • Germany
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ÉNOXIMONE
Manufacturer
CARINOPHARM (ALLEMAGNE)
Country
France (FR)
ATC code
C01CE03
ATC class
Enoximone
Defined daily dose
1 g, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955602644
    10 ampoule(s) en verre de 20 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Enoximone in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All enoximone products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Germany · Perfan
  • United Kingdom (Northern Ireland) · Perfan
  • Italy · Perfan
  • Netherlands · Perfan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/40dbb3fc-4f6f-46cd-8f7a-fc3459dafea6
GET /v1/drugs/40dbb3fc-4f6f-46cd-8f7a-fc3459dafea6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60938745",
  "date_amm": "1987-10-27",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ÉNOXIMONE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable à diluer",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about enoximone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console